Arisaph Pharmaceuticals Company
Arisaph Pharmaceuticals, Inc., a biopharmaceutical company, focuses on developing therapies for cancer, cardiovascular disease, and diabetes. Its products include dipeptidylpeptidase IV inhibitors, stable GLP-1 agonists, HDL modulators and plaque reducers, and tumor activated pro-soft drugs. The company was founded in 1999 and is based in Boston, Massachusetts.
Industry:
Geroscience
Headquarters:
Boston, Massachusetts, United States
Zip:
11-50
Founded Date:
1999-01-01
Employees Number:
11-50
Investors Number:
10000000
Total Funding:
$1M to $10M
Estimated Revenue:
$1M to $10M
Last Funding Date:
Venture - Series Unknown
Last Funding Type:
info@arisaph.com
Register and Claim Ownership